Lenalidomide combined with mismatched microtransplantation for acute myeloid leukemia

Am J Hematol. 2018 Oct;93(10):E331-E333. doi: 10.1002/ajh.25218. Epub 2018 Aug 14.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Allografts
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Consolidation Chemotherapy
  • Cytarabine / therapeutic use
  • Drug Evaluation
  • Fatal Outcome
  • Female
  • Genes, sry
  • Histocompatibility
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lenalidomide / therapeutic use*
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / therapy*
  • Maintenance Chemotherapy
  • Male
  • Peripheral Blood Stem Cell Transplantation*
  • Transplantation Chimera

Substances

  • Antineoplastic Agents
  • Immunologic Factors
  • Cytarabine
  • Lenalidomide